Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2008 (2008), Article ID 326464, 8 pages
http://dx.doi.org/10.1155/2008/326464
Research Article

Peptide Mimicrying Between SARS Coronavirus Spike Protein and Human Proteins Reacts with SARS Patient Serum

1Department of Molecular Science and Engineering, Center for Biomedical Industries, National Taipei University of Technology, Taipei 106, Taiwan
2Institute of Polymeric Science, National Taiwan University, Taipei 10617, Taiwan
3Center for Biomedical Industries, National Taipei University of Technology, Taipei 106, Taiwan
4Institute of Biomedical Technology, Taipei Medical University, Taipei 110, Taiwan
5Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan

Received 1 October 2007; Accepted 24 December 2007

Academic Editor: Daniel Howard

Copyright © 2008 K.-Y. Hwa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. D. Christian, S. M. Poutanen, M. R. Loutfy, M. P. Muller, and D. E. Low, “Severe acute respiratory syndrome,” Clinical Infectious Diseases, vol. 38, pp. 1420–1427, 2004. View at Publisher · View at Google Scholar
  2. T. Kuiken, R. A. M. Fouchier, M. Schutten et al., “Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome,” Lancet, vol. 362, no. 9380, pp. 263–270, 2003. View at Publisher · View at Google Scholar
  3. N. Lee, D. Hui, A. Wu et al., “A major outbreak of severe acute respiratory syndrome in Hong Kong,” New England Journal of Medicine, vol. 348, no. 20, pp. 1986–1994, 2003. View at Publisher · View at Google Scholar
  4. S. M. Poutanen, D. E. Low, B. Henry et al., “Identification of severe acute respiratory syndrome in Canada,” New England Journal of Medicine, vol. 348, no. 20, pp. 1995–2005, 2003. View at Publisher · View at Google Scholar
  5. K. W. Tsang, P. L. Ho, G. C. Ooi et al., “A cluster of cases of severe acute respiratory syndrome in Hong Kong,” New England Journal of Medicine, vol. 348, no. 20, pp. 1977–1985, 2003. View at Publisher · View at Google Scholar
  6. R. P. Wenzel and M. B. Edmond, “Managing SARS amidst uncertainty,” New England Journal of Medicine, vol. 348, no. 20, pp. 1947–1948, 2003. View at Publisher · View at Google Scholar
  7. C. Drosten, S. Günther, W. Preiser et al., “Identification of a novel coronavirus in patients with severe acute respiratory syndrome,” New England Journal of Medicine, vol. 348, no. 20, pp. 1967–1976, 2003. View at Publisher · View at Google Scholar
  8. T. G. Ksiazek, D. Erdman, C. S. Goldsmith et al., “A novel coronavirus associated with severe acute respiratory syndrome,” New England Journal of Medicine, vol. 348, no. 20, pp. 1953–1966, 2003. View at Publisher · View at Google Scholar
  9. P. A. Rota, M. S. Oberste, S. S. Monroe et al., “Characterization of a novel coronavirus associated with severe acute respiratory syndrome,” Science, vol. 300, no. 5624, pp. 1394–1399, 2003. View at Publisher · View at Google Scholar
  10. M. A. Marra, S. J. M. Jones, C. R. Astell et al., “The genome sequence of the SARS-associated coronavirus,” Science, vol. 300, no. 5624, pp. 1399–1404, 2003. View at Publisher · View at Google Scholar
  11. A. Bonavia, B. D. Zelus, D. E. Wentworth, P. J. Talbot, and K. V. Holmes, “Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E,” Journal of Virology, vol. 77, no. 4, pp. 2530–2538, 2003. View at Publisher · View at Google Scholar
  12. B. J. Bosch, B. E. Martina, R. van der Zee et al., “Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 22, pp. 8455–8460, 2004. View at Publisher · View at Google Scholar
  13. Y. He, Y. Zhou, H. Wu et al., “Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines,” Journal of Immunology, vol. 173, no. 6, pp. 4050–4057, 2004. View at Google Scholar
  14. W. Li, M. J. Moore, N. Vasllieva et al., “Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus,” Nature, vol. 426, no. 6965, pp. 450–454, 2003. View at Publisher · View at Google Scholar
  15. S. K. Wong, W. Li, M. J. Moore, H. Choe, and M. Farzan, “A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2,” Journal of Biological Chemistry, vol. 279, no. 5, pp. 3197–3201, 2004. View at Publisher · View at Google Scholar
  16. J. Sui, W. Li, A. Murakami et al., “Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 8, pp. 2536–2541, 2004. View at Publisher · View at Google Scholar
  17. M. B. A. Oldstone, “Molecular mimicry and immune-mediated diseases,” The FASEB Journal, vol. 12, no. 13, pp. 1255–1265, 1998. View at Google Scholar
  18. A. S. Kolaskar and P. C. Tongaonkar, “A semi-empirical method for prediction of antigenic determinants on protein antigens,” FEBS Letters, vol. 276, no. 1-2, pp. 172–174, 1990. View at Publisher · View at Google Scholar
  19. B. Rost, G. Yachdav, and J. Liu, “The predict protein server,” Nucleic Acids Research, vol. 32, Web Server Issue, pp. 321–326, 2004. View at Publisher · View at Google Scholar
  20. D. Frishman and P. Argos, “Incorporation of long-distance interactions into a secondary structure prediction algorithm,” Protein Engineering, vol. 9, no. 2, pp. 133–142, 1996. View at Publisher · View at Google Scholar
  21. A. Krogh, B. Larsson, G. von Heijne, and E. L. L. Sonnhammer, “Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes,” Journal of Molecular Biology, vol. 305, no. 3, pp. 567–580, 2001. View at Publisher · View at Google Scholar
  22. D. Eisenberg, R. M. Weiss, and T. C. Terwilliger, “The hydrophobic moment detects periodicity in protein hydrophobicity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 81, no. 1, pp. 140–144, 1984. View at Publisher · View at Google Scholar
  23. W. Gish and D. J. States, “Identification of protein coding regions by database similarity search,” Nature Genetics, vol. 3, no. 3, pp. 266–272, 1993. View at Publisher · View at Google Scholar
  24. T. M. Yeh, H. C. Chang, C. C. Liang, J. J. Wu, and M. F. Liu, “Deoxyribonuclease-inhibtory antibodies in systemic lupus erythematosus,” Journal of Biomedical Science, vol. 10, no. 5, pp. 544–551, 2003. View at Publisher · View at Google Scholar
  25. S. K. Wong, W. Li, M. J. Moore, H. Choe, and M. Farzan, “A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2,” Journal of Biological Chemistry, vol. 279, no. 5, pp. 3197–3201, 2004. View at Publisher · View at Google Scholar
  26. J. J. Breslin, I. Mork, M. K. Smith et al., “Human coronavirus 229E: receptor binding domain and neutralization by soluble receptor at 37°C,” Journal of Virology, vol. 77, no. 7, pp. 4435–4438, 2003. View at Publisher · View at Google Scholar
  27. R. Wheatland, “Molecular mimicry of ACTH in SARS—implications for corticosteroid treatment and prophylaxis,” Medical Hypotheses, vol. 63, no. 5, pp. 855–862, 2004. View at Publisher · View at Google Scholar
  28. R. Y. Kao, W. H. Tsui, T. S. Lee et al., “Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetic,” Chemistry & Biology, vol. 11, no. 9, pp. 1293–1299, 2004. View at Publisher · View at Google Scholar
  29. D. P. Han, A. Penn-Nicholson, and M. W. Cho, “Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor,” Virology, vol. 350, no. 1, pp. 15–25, 2006. View at Publisher · View at Google Scholar